Glenmark Pharmaceuticals gains as its arm receives final ANDA approval for Telmisartan Tablets

09 Jul 2014 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs 564.85, up by 2.50 points or 0.44% from its previous closing of Rs 562.35 on the BSE.

The scrip opened at Rs 568.00 and has touched a high and low of Rs 570.00 and Rs 556.00 respectively. So far 34600 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 1 has touched a 52 week high of Rs 640.35 on 02-May-2014 and a 52 week low of Rs 489.10 on 27-Nov-2013.

Last one week high and low of the scrip stood at Rs 621.00 and Rs 555.35 respectively. The current market cap of the company is Rs 15289.24 crore.

The promoters holding in the company stood at 48.29% while Institutions and Non-Institutions held 41.20% and 10.52% respectively.

Glenmark Generics Inc (GGI), a step down subsidiary of Glenmark Pharmaceuticals has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

Telmisartan Tablets are Glenmark’s generic version of Boehringer Ingelheim’s Micardis. Telmisartan is indicated for the treatment of hypertension. The approval is for the 20mg, 40mg and 80mg tablets. For the 12 month period ending March 2014, Telmisartan garnered annual sales of USD 250 Million according to IMS Health.

Glenmark’s current portfolio consists of 92 products authorized for distribution in the U.S. marketplace and 73 ANDA’s pending approval with the US FDA. In addition to these internal filings, GGI continues to identify and explore external development partnerships to supplement and accelerate the growth of the existing pipeline and portfolio.

Glenmark Pharma Share Price

2009.90 39.15 (1.99%)
27-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1636.05
Dr. Reddys Lab 1240.00
Cipla 1313.20
Zydus Lifesciences 895.85
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×